8-K: Beauty Health Company Appoints Menezes and Lewis as Executive Officers, Bolstering Leadership Team

The Beauty Health Company designates Ronald Menezes as an executive officer and Section 16 Officer, and Sheri Lewis as an executive officer and Section 16 Officer, reflecting the expanded scope of their roles.

Summary

• The Beauty Health Company has designated Ronald Menezes, Chief Revenue Officer, and Sheri Lewis, Chief Supply Chain and Operations Officer, as executive officers and Section 16 Officers.
• This decision reflects the increased scope of their duties, which now include policy-making functions.
• Mr. Menezes's annual base salary is $450,000, and he is eligible for an annual discretionary cash bonus with a target equal to 60% of his annual base salary.
• He also received a one-time cash bonus of $100,000 and a one-time long-term incentive new hire equity award of $800,000 in RSUs.
• Ms. Lewis's annual base salary is $485,000, and she is eligible for an annual discretionary cash bonus with a target equal to 60% of her annual base salary.
• She also received a one-time cash bonus of $75,000, a one-time long-term incentive new hire equity award of $1,181,250 in RSUs, and a one-time long-term incentive new hire grant of equity in the form of PSUs with a grant-date value of $393,750.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to the appointments of experienced executives and the company's stated goals for growth and profitability. The language used is optimistic and forward-looking.

Positives

• The designation of Mr. Menezes and Ms. Lewis as executive officers reflects their increased responsibilities and importance to the company.
• The compensation packages for both executives are competitive and incentivize performance.

Future Outlook

The company aims to achieve consistent sales and profit growth by elevating experiences and results for clients.

Management Comments

• Marla Beck commented on the appointments, We are thrilled to welcome Ron and Carrie to the executive team as we continue to drive the transformation of Beauty Health to elevate experiences and results for our clients.
• Marla Beck stated that the Board of Directors and she are confident that their expertise further strengthens the senior leadership team and will enable the company to achieve its near-term priorities, positioning Beauty Health for consistent sales and profit growth to unlock Hydrafacials growth potential.
• Sheri Lewis stated that she is thrilled to join The Beauty Health Company at such a pivotal moment in its history and is confident in the company's ability to make marked progress in key operational areas to drive results across the entire value stream as they grow and evolve the business.

Industry Context

The appointments reflect a focus on strengthening commercial leadership and supply chain operations within the beauty and medical aesthetics industry, where competition for market share and efficient operations is intense.

Comparison to Industry Standards

• The compensation packages offered to Mr. Menezes and Ms. Lewis appear to be competitive with industry standards for executive roles at publicly traded companies in the beauty and medical aesthetics sector.
• Comparing to similar roles at companies like Allergan (now part of AbbVie) and Galderma, the base salaries and bonus structures are within a reasonable range.
• The equity grants are also a common practice to align executive interests with shareholder value.

Management Changes

Stakeholder Impact

• Shareholders may view the appointments positively, anticipating improved performance and growth.
• Employees may experience changes in leadership and potentially new strategies.
• Customers and partners may benefit from enhanced product innovation and go-to-market strategies.

Key Dates